‘Universal’ access for MDR-TB limited without the involvement of the private sector. Go to Publication You Might Also Like Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis. April 20, 2014 Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease August 30, 2019 XDR tuberculosis in India: what’s in a name? July 7, 2007 Molecular diagnosis of cystic fibrosis in Indian patients–a preliminary report. April 20, 2003 Prevalence of venous thromboembolism in acute exacerbations of chronic obstructive pulmonary disease: an Indian perspective. October 10, 2011
Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis. April 20, 2014
Prevalence of venous thromboembolism in acute exacerbations of chronic obstructive pulmonary disease: an Indian perspective. October 10, 2011